T1	PROC 46 95	ENSAYO CLÍNICO ABIERTO, ALEATORIZADO Y CONTROLADO
T4	Route 143 157	INTRABRONQUIAL
T7	LIVB 207 216	PACIENTES
#2	AnnotatorNotes T7	C0030705; Patients; Patient or Disabled Group
T12	LIVB 305 314	PACIENTES
#4	AnnotatorNotes T12	C0030705; Patients; Patient or Disabled Group
T17	LIVB 392 401	pacientes
#6	AnnotatorNotes T17	C0030705; Patients; Patient or Disabled Group
T19	LIVB 466 483	Pacientes adultos
T20	Age 476 483	adultos
T21	Age 484 492	≥18 años
T22	LIVB 536 545	Pacientes
#7	AnnotatorNotes T22	C0030705; Patients; Patient or Disabled Group
T23	PROC 563 590	trasplante uni o bipulmonar
T24	PROC 594 605	Diagnóstico
#8	AnnotatorNotes T24	C0011900; Diagnosis; Diagnostic Procedure
T25	DISO 621 624	BOS
T26	PROC 631 635	FEV1
T27	PROC 645 648	FEF
T28	Neg_cue 674 677	sin
T29	Negated 678 688	otra causa
T30	Duration 711 730	los últimos 6 meses
T31	PROC 774 792	trasplante lobular
T32	PROC 809 839	trasplante de corazón y pulmón
T33	DISO 843 852	Infección
#9	AnnotatorNotes T33	C0009450; Communicable Diseases; Disease or Syndrome | C3714514; Infection; Pathologic Function
T34	Neg_cue 915 917	no
T35	PROC 918 925	tratado
T36	Negated 918 925	tratado
T37	Neg_cue 981 988	excepto
T38	DISO 989 1008	basocelular cutáneo
T39	Negated 989 1008	basocelular cutáneo
T40	DISO 1011 1028	carcinoma in situ
#10	AnnotatorNotes T40	C0007099; Carcinoma in Situ; Neoplastic Process | C0851135; In situ cancer; Neoplastic Process
T41	Negated 1011 1028	carcinoma in situ
T42	DISO 1033 1068	Enfermedades autoinmunes sistémicas
T43	DISO 1073 1105	Infección activa por VIH/VHB/VHC
T44	PROC 1122 1131	serología
#11	AnnotatorNotes T44	C0036743; Serologic tests; Laboratory Procedure
T45	PROC 1134 1137	PCR
#12	AnnotatorNotes T45	C0032520; Polymerase Chain Reaction; Molecular Biology Research Technique | C0201657; C-reactive protein measurement; Laboratory Procedure
T46	DISO 1142 1176	Estenosis de la vía aérea proximal
T48	LIVB 1201 1208	mujeres
#14	AnnotatorNotes T48	C0043210; Woman; Population Group | C0242665; wife; Family Group
T49	PROC 1329 1345	Estado funcional
T52	PHYS 1418 1425	vigilia
#15	AnnotatorNotes T52	C0043012; Wakefulness; Mental Process
T55	Duration 1518 1536	inferior a 3 meses
T56	DISO 1542 1559	Hipersensibilidad
#16	AnnotatorNotes T56	C0020517; Hypersensitivity; Pathologic Function | C0429891; Hypersensitivity finding; Finding | C0585186; Cutaneous hypersensitivity; Disease or Syndrome
T57	CHEM 1618 1621	SCC
#17	AnnotatorNotes T57	C0206651; Clear Cell Sarcoma of Soft Tissue; Neoplastic Process
T58	LIVB 1680 1692	investigador
#18	AnnotatorNotes T58	C0035173; Research Personnel; Professional or Occupational Group
T59	LIVB 1722 1730	paciente
#19	AnnotatorNotes T59	C0030705; Patients; Patient or Disabled Group
T60	PROC 1753 1767	ensayo clínico
#20	AnnotatorNotes T60	C0008976; Clinical Trials; Research Activity
T61	DISO 894 907	Rechazo agudo
#21	AnnotatorNotes T61	Acute rejection of lung transplant (C2315624)
T62	DISO 960 979	Historia oncológica
T5	DISO 221 260	RECHAZO CRÓNICO DE TRASPLANTE DE PULMÓN
#1	AnnotatorNotes T5	Chronic rejection of lung transplant C2317104 (pathological function)
T6	DISO 319 358	RECHAZO CRÓNICO DE TRASPLANTE DE PULMÓN
T10	Spec_cue 1229 1238	planeando
T11	PHYS 1248 1259	embarazadas
T13	Speculated 1248 1259	embarazadas
T15	PROC 1318 1324	ensayo
T16	Spec_cue 1266 1273	quieran
T47	PHYS 1283 1293	embarazada
T64	Speculated 1283 1293	embarazada
T54	PROC 101 157	EVALUAR LA SEGURIDAD DE LA ADMINISTRACIÓN INTRABRONQUIAL
T3	LIVB 1180 1199	Mujeres embarazadas
T18	CHEM 1575 1586	componentes
T9	PROC 425 461	consentimiento informado por escrito
T2	PROC 262 281	Estudio ENDOSC-CLAD
T14	CHEM 161 203	CÉLULAS DEL ESTROMA MESENQUIMAL ALOGÉNICAS
